Description
Developer of tissue engineering and 3D bioprinting technologies designed to advance human longevity by replacing organs that fail with age.
Contact Information
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
2. Out of Business | 01-Jul-2019 | Completed | Out of Business | |||
1. Accelerator/Incubator | Completed | Startup |